Literature DB >> 18161527

Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells.

Nicholas J Megjugorac1, Evan S Jacobs, Alexander G Izaguirre, Thaddeus C George, Gunjan Gupta, Patricia Fitzgerald-Bocarsly.   

Abstract

Plasmacytoid dendritic cells (pDC) are well-known for their ability to produce large quantities of interferon-alpha (IFN-alpha) in response to viruses. In addition, pDC produce IFN-alpha in response to HSV-infected cells. We demonstrate that both tonsil and PBMC contain pDC that respond to stimulation with HSV either in suspension or in tonsil tissue-fragment culture. We hypothesized that other DC subsets acquire virus in the periphery and deliver the interferongenic signals to the pDC in the draining lymphoid tissue. As a model for pDC/myeloid DC interaction, we studied the interaction of pDC derived from blood with HSV-infected and uninfected monocyte derived dendritic cells (MDDC). Infected, but not uninfected, MDDC induced IFN-alpha in pDC. To further study pDC/infected MDDC interactions, we labeled MDDC with fluorescent cell trackers PKH67 or CFSE prior to infection with HSV and co-cultured with pDC. Cells were then analyzed using conventional and imaging flow cytometry. In addition, we infected MDDC with a GFP-expressing HSV prior to co-culture with pDC. Using traditional flow cytometry, we observed that pDC became fluorescent after co-incubation with uninfected or infected, fluorescently labeled MDDC, indicating that MDDC transferred fluorescent protein and membrane to pDC. By imaging flow cytometry, we observed formation of conjugates between pDC and MDDC as well as transfer and internalization of cellular components from the labeled MDDC by pDC, with preferential uptake from, and association with, infected vs. uninfected MDDC. These studies demonstrate that MDDC infected with HSV are able to stimulate IFN-alpha and chemokine production by pDC through the transfer of cellular materials from the HSV-infected MDDC to the pDC. Together, these observations indicate that heterogeneous populations of DC interact to generate an effective IFN-alpha response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18161527     DOI: 10.1080/08820130701715845

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  21 in total

1.  Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.

Authors:  Pratik Deb; Jihong Dai; Sukhwinder Singh; Evelyne Kalyoussef; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2020-05-29       Impact factor: 5.422

Review 2.  Biting Off What Can Be Chewed: Trogocytosis in Health, Infection, and Disease.

Authors:  Akhila Bettadapur; Hannah W Miller; Katherine S Ralston
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 3.  Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.

Authors:  Patricia Fitzgerald-Bocarsly; Evan S Jacobs
Journal:  J Leukoc Biol       Date:  2010-02-09       Impact factor: 4.962

4.  Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity.

Authors:  Lisa K Ryan; Jihong Dai; Zhiwei Yin; Nicholas Megjugorac; Victoria Uhlhorn; Sunghan Yim; Kyell D Schwartz; Joshua M Abrahams; Gill Diamond; Patricia Fitzgerald-Bocarsly
Journal:  J Leukoc Biol       Date:  2011-05-06       Impact factor: 4.962

5.  Optimized protocol for the isolation of spleen-resident murine neutrophils.

Authors:  Christine M Coquery; William Loo; Maja Buszko; Joanne Lannigan; Loren D Erickson
Journal:  Cytometry A       Date:  2012-07-03       Impact factor: 4.355

6.  Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

Authors:  Stefan Nierkens; Martijn H den Brok; Zacharias Garcia; Susan Togher; Jori Wagenaars; Melissa Wassink; Louis Boon; Theo J Ruers; Carl G Figdor; Stephen P Schoenberger; Gosse J Adema; Edith M Janssen
Journal:  Cancer Res       Date:  2011-07-25       Impact factor: 12.701

7.  Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.

Authors:  Jennifer H Huch; Anthony L Cunningham; Ann M Arvin; Najla Nasr; Saskia J A M Santegoets; Eric Slobedman; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

8.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Jihed Chehimi; Emmanouil Papasavvas; Costin Tomescu; Bethsebah Gekonge; Shaheed Abdulhaqq; Andrea Raymond; Aidan Hancock; Kavita Vinekar; Craig Carty; Griffin Reynolds; Maxwell Pistilli; Karam Mounzer; Jay Kostman; Luis J Montaner
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

10.  Human plasmacytoid dendritic cells mount a distinct antiviral response to virus-infected cells.

Authors:  Tae Jin Yun; Suzu Igarashi; Haoquan Zhao; Oriana A Perez; Marcus R Pereira; Emmanuel Zorn; Yufeng Shen; Felicia Goodrum; Adeeb Rahman; Peter A Sims; Donna L Farber; Boris Reizis
Journal:  Sci Immunol       Date:  2021-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.